Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety, tolerability and antiviral activity
between once-daily (QD) and twice-daily (BID) dosing of lopinavir/ritonavir and to further
characterize the pharmacokinetics of once-daily dosing of lopinavir/ritonavir.